Joshua Foukas - 19 Feb 2026 Form 4 Insider Report for USANA HEALTH SCIENCES INC (USNA)

Role
CHIEF LEGAL OFFICER
Signature
/s/ Joshua Foukas, Attorney-in-Fact
Issuer symbol
USNA
Transactions as of
19 Feb 2026
Net transactions value
-$95,220
Form type
4
Filing time
23 Feb 2026, 19:12:29 UTC
Previous filing
10 Feb 2026
Next filing
03 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Foukas Joshua CHIEF LEGAL OFFICER 3838 WEST PARKWAY BLVD., SALT LAKE CITY /s/ Joshua Foukas, Attorney-in-Fact 23 Feb 2026 0001748208

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction USNA Common Stock Sale $95,220 -4,461 -100% $21.34 0 20 Feb 2026 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction USNA Restricted Stock Units Award $0 +36,662 +100% $0.000000 73,270 19 Feb 2026 Common Stock 36,662 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of USNA common stock.
F2 On February 19th 2026, the reporting person was granted restricted stock units, vesting at 25% on each 19th of February thereafter.